Published in J Exp Med on February 28, 2011
Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov (2013) 4.72
Integrating mechanisms of pulmonary fibrosis. J Exp Med (2011) 3.57
Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome. Nat Immunol (2013) 3.08
Cytokine production and inflammation drive autophagy in the tumor microenvironment: role of stromal caveolin-1 as a key regulator. Cell Cycle (2011) 2.68
Reactive oxygen species in inflammation and tissue injury. Antioxid Redox Signal (2013) 2.59
Autophagy links inflammasomes to atherosclerotic progression. Cell Metab (2012) 2.08
Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy. Antioxid Redox Signal (2012) 2.05
Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes. Diabetes (2012) 1.62
TLR2/MyD88/NF-κB pathway, reactive oxygen species, potassium efflux activates NLRP3/ASC inflammasome during respiratory syncytial virus infection. PLoS One (2012) 1.48
Importance of Toll-like receptor 2 in mitochondrial dysfunction during polymicrobial sepsis. Anesthesiology (2014) 1.43
Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers. J Hematol Oncol (2013) 1.42
Hydrogen peroxide fuels aging, inflammation, cancer metabolism and metastasis: the seed and soil also needs "fertilizer". Cell Cycle (2011) 1.36
Mitochondrial reactive oxygen species induces NLRP3-dependent lysosomal damage and inflammasome activation. J Immunol (2013) 1.34
Aging and osteoarthritis. Curr Opin Rheumatol (2011) 1.31
Mitochondria in innate immunity. EMBO Rep (2011) 1.31
AMP-activated protein kinase, stress responses and cardiovascular diseases. Clin Sci (Lond) (2012) 1.29
Inflammasomes in neuroinflammation and changes in brain function: a focused review. Front Neurosci (2014) 1.26
The Yin and Yang of Toll-like receptors in cancer. Oncogene (2013) 1.23
Age-related macular degeneration in the aspect of chronic low-grade inflammation (pathophysiological parainflammation). Mediators Inflamm (2014) 1.20
Mitochondrial retrograde signaling at the crossroads of tumor bioenergetics, genetics and epigenetics. Mitochondrion (2013) 1.17
Defects in mitochondrial clearance predispose human monocytes to interleukin-1β hypersecretion. J Biol Chem (2013) 1.15
Role of lysosome rupture in controlling Nlrp3 signaling and necrotic cell death. Cell Cycle (2013) 1.14
Mechanism of inflammation in age-related macular degeneration. Mediators Inflamm (2012) 1.14
Cellular stress response and innate immune signaling: integrating pathways in host defense and inflammation. J Leukoc Biol (2013) 1.10
Oxidative stress and inflammation: essential partners in alcoholic liver disease. Int J Hepatol (2012) 1.05
Angiogenesis inhibitor vasohibin-1 enhances stress resistance of endothelial cells via induction of SOD2 and SIRT1. PLoS One (2012) 1.02
Mitochondrial dysfunction and mitophagy: the beginning and end to diabetic nephropathy? Br J Pharmacol (2014) 1.02
Molecular basis of asbestos-induced lung disease. Annu Rev Pathol (2013) 1.01
Antioxidants that protect mitochondria reduce interleukin-6 and oxidative stress, improve mitochondrial function, and reduce biochemical markers of organ dysfunction in a rat model of acute sepsis. Br J Anaesth (2013) 1.00
The role of sirtuins in modulating redox stressors. Free Radic Biol Med (2011) 0.99
Self-eating in the plaque: what macrophage autophagy reveals about atherosclerosis. Trends Endocrinol Metab (2014) 0.98
Inflammatory response of microglial BV-2 cells includes a glycolytic shift and is modulated by mitochondrial glucose-regulated protein 75/mortalin. FEBS Lett (2013) 0.95
PGC-1-related coactivator (PRC), a sensor of metabolic stress, orchestrates a redox-sensitive program of inflammatory gene expression. J Biol Chem (2011) 0.95
ROS homeostasis and metabolism: a dangerous liason in cancer cells. Cell Death Dis (2016) 0.94
Apolipoprotein D takes center stage in the stress response of the aging and degenerative brain. Neurobiol Aging (2014) 0.93
Mitochondria in lung diseases. Expert Rev Respir Med (2013) 0.93
Complement factor B is the downstream effector of TLRs and plays an important role in a mouse model of severe sepsis. J Immunol (2013) 0.93
Identification of the HSPB4/TLR2/NF-κB axis in macrophage as a therapeutic target for sterile inflammation of the cornea. EMBO Mol Med (2012) 0.93
Nonhematopoietic toll-like receptor 2 contributes to neutrophil and cardiac function impairment during polymicrobial sepsis. Shock (2011) 0.92
Chronic inflammation and immunologic-based constraints in malignant disease. Immunotherapy (2011) 0.91
Mechanism of inflammation in age-related macular degeneration: an up-to-date on genetic landmarks. Mediators Inflamm (2013) 0.91
New tricks from an old dog: mitochondrial redox signaling in cellular inflammation. Semin Immunol (2013) 0.91
Reactive oxygen species, apoptosis, antimicrobial peptides and human inflammatory diseases. Pharmaceuticals (Basel) (2015) 0.91
The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease. J Exp Med (2016) 0.90
The Role of the Reactive Oxygen Species and Oxidative Stress in the Pathomechanism of the Age-Related Ocular Diseases and Other Pathologies of the Anterior and Posterior Eye Segments in Adults. Oxid Med Cell Longev (2016) 0.88
Release of IL-1 β triggered by Milan summer PM10: molecular pathways involved in the cytokine release. Biomed Res Int (2013) 0.87
Mitochondria: redox metabolism and dysfunction. Biochem Res Int (2012) 0.87
Genome integrity, stem cells and hyaluronan. Aging (Albany NY) (2012) 0.87
Mitochondrial genetic background modifies the relationship between traffic-related air pollution exposure and systemic biomarkers of inflammation. PLoS One (2013) 0.87
Targeting inflammasomes in rheumatic diseases. Nat Rev Rheumatol (2013) 0.86
Importance of PdpC, IglC, IglI, and IglG for modulation of a host cell death pathway induced by Francisella tularensis. Infect Immun (2013) 0.86
Environmental immune disruptors, inflammation and cancer risk. Carcinogenesis (2015) 0.86
Evaluating the Oxidative Stress in Inflammation: Role of Melatonin. Int J Mol Sci (2015) 0.84
Mitigation of murine focal cerebral ischemia by the hypocretin/orexin system is associated with reduced inflammation. Stroke (2013) 0.84
Thymoquinone prevents and ameliorates dextran sulfate sodium-induced colitis in mice. Dig Dis Sci (2012) 0.84
Impaired mitochondrial energy production and ABC transporter function-A crucial interconnection in dementing proteopathies of the brain. Mech Ageing Dev (2013) 0.84
Transcriptional impact of dietary methionine restriction on systemic inflammation: relevance to biomarkers of metabolic disease during aging. Biofactors (2013) 0.84
Mammalian target of rapamycin complex 2 regulates inflammatory response to stress. Inflamm Res (2012) 0.83
MicroRNAs regulate the chaperone network in cerebral ischemia. Transl Stroke Res (2013) 0.83
Autophagy: an emerging therapeutic target in vascular diseases. Br J Pharmacol (2015) 0.82
Redox signaling in acute pancreatitis. Redox Biol (2015) 0.82
IRG1 induced by heme oxygenase-1/carbon monoxide inhibits LPS-mediated sepsis and pro-inflammatory cytokine production. Cell Mol Immunol (2015) 0.82
TNFR1/phox interaction and TNFR1 mitochondrial translocation Thwart silica-induced pulmonary fibrosis. J Immunol (2014) 0.82
The psychoimmunology of lyme/tick-borne diseases and its association with neuropsychiatric symptoms. Open Neurol J (2012) 0.82
Cross-talk between E. coli strains and a human colorectal adenocarcinoma-derived cell line. Sci Rep (2013) 0.82
Toll-like receptor 4 is essential to preserving cardiac function and survival in low-grade polymicrobial sepsis. Anesthesiology (2014) 0.81
HBV-induced ROS accumulation promotes hepatocarcinogenesis through Snail-mediated epigenetic silencing of SOCS3. Cell Death Differ (2016) 0.81
Regulation of oxidative stress by methylation-controlled J protein controls macrophage responses to inflammatory insults. J Infect Dis (2014) 0.81
Antioxidant activity of flavonoids evaluated with myoglobin method. Plant Cell Rep (2011) 0.81
Lignans from Carthamus tinctorius suppress tryptophan breakdown via indoleamine 2,3-dioxygenase. Phytomedicine (2013) 0.81
Biocompatibility of cerium dioxide and silicon dioxide nanoparticles with endothelial cells. Beilstein J Nanotechnol (2014) 0.81
Small heterodimer partner-targeting therapy inhibits systemic inflammatory responses through mitochondrial uncoupling protein 2. PLoS One (2013) 0.81
Dual role of superoxide dismutase 2 induced in activated microglia: oxidative stress tolerance and convergence of inflammatory responses. J Biol Chem (2015) 0.80
Osteoarthritis: toward a comprehensive understanding of pathological mechanism. Bone Res (2017) 0.80
Mitochondrial reactive oxygen species accelerate the expression of heme carrier protein 1 and enhance photodynamic cancer therapy effect. J Clin Biochem Nutr (2014) 0.79
A Mitochondrion-Targeted Antioxidant Ameliorates Isoflurane-Induced Cognitive Deficits in Aging Mice. PLoS One (2015) 0.79
Central Nervous System Injury and Nicotinamide Adenine Dinucleotide Phosphate Oxidase: Oxidative Stress and Therapeutic Targets. J Neurotrauma (2016) 0.78
Distinct energy requirements for human memory CD4 T-cell homeostatic functions. FASEB J (2012) 0.78
Mitochondrial haplogroups modify the effect of black carbon on age-related cognitive impairment. Environ Health (2014) 0.78
Mitochondrial DNA copy number and chronic lymphocytic leukemia/small lymphocytic lymphoma risk in two prospective studies. Cancer Epidemiol Biomarkers Prev (2014) 0.78
The association between physical activity and sex-specific oxidative stress in older adults. J Sports Sci Med (2013) 0.78
Skeletal muscle mitochondrial depletion and dysfunction in chronic kidney disease. Int J Clin Exp Med (2013) 0.78
Activation of Proinflammatory Responses in Cells of the Airway Mucosa by Particulate Matter: Oxidant- and Non-Oxidant-Mediated Triggering Mechanisms. Biomolecules (2015) 0.78
Effects of nanoporous alumina on inflammatory cell response. J Biomed Mater Res A (2013) 0.77
Colchicine prevents NSAID-induced small intestinal injury by inhibiting activation of the NLRP3 inflammasome. Sci Rep (2016) 0.77
1'-Acetoxychavicol acetate promotes caspase 3-activated glioblastoma cell death by overcoming enhanced cytokine expression. Oncol Lett (2013) 0.77
Inflammatory response mechanisms exacerbating hypoxemia in coexistent pulmonary fibrosis and sleep apnea. Mediators Inflamm (2015) 0.77
Expression of 2',3'-cyclic nucleotide 3'-phosphodiesterase (CNPase) and its roles in activated microglia in vivo and in vitro. J Neuroinflammation (2014) 0.77
The effects of aging on the development of osteoarthritis. HSS J (2011) 0.77
Nuclear cytoplasmic trafficking of proteins is a major response of human fibroblasts to oxidative stress. J Proteome Res (2014) 0.76
Autophagy is associated with cell fate in the process of macrophage-derived foam cells formation and progress. J Biomed Sci (2016) 0.76
Carboxylesterase 1 Is Regulated by Hepatocyte Nuclear Factor 4α and Protects Against Alcohol- and MCD diet-induced Liver Injury. Sci Rep (2016) 0.76
Mitochondrial dysfunction in inflammatory responses and cellular senescence: pathogenesis and pharmacological targets for chronic lung diseases. Br J Pharmacol (2016) 0.76
Cu(II) enhances the effect of Alzheimer's amyloid-β peptide on microglial activation. J Neuroinflammation (2015) 0.75
Amelioration of mitochondrial dysfunction-induced insulin resistance in differentiated 3T3-L1 adipocytes via inhibition of NF-κB pathways. Int J Mol Sci (2014) 0.75
Laparotomy in mice induces blood cell expression of inflammatory and stress genes. J Interferon Cytokine Res (2014) 0.75
Chasing flies because time flies. J Innate Immun (2014) 0.75
Transcription factor NF-kappa B represses ANT1 transcription and leads to mitochondrial dysfunctions. Sci Rep (2017) 0.75
Modulation of Innate Immune Signalling by Lipid-Mediated MAVS Transmembrane Domain Oligomerization. PLoS One (2015) 0.75
Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science (2008) 16.54
A role for mitochondria in NLRP3 inflammasome activation. Nature (2010) 13.21
The inflammasomes: guardians of the body. Annu Rev Immunol (2009) 12.89
Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell (2005) 9.16
Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol (2010) 9.02
Mitochondrial respiratory-chain diseases. N Engl J Med (2003) 8.68
Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med (2010) 7.31
Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell (1999) 5.01
Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS). J Exp Med (2011) 4.81
The inflammasomes: mechanisms of activation and function. Curr Opin Immunol (2010) 3.41
Superoxide dismutase 1 regulates caspase-1 and endotoxic shock. Nat Immunol (2008) 2.72
The role of mitochondria in the pathogenesis of type 2 diabetes. Endocr Rev (2010) 2.59
Concerted action of wild-type and mutant TNF receptors enhances inflammation in TNF receptor 1-associated periodic fever syndrome. Proc Natl Acad Sci U S A (2010) 2.20
Defective mitochondrial biogenesis: a hallmark of the high cardiovascular risk in the metabolic syndrome? Circ Res (2007) 1.62
Cytokine-based therapies for Crohn's disease--new paradigms. N Engl J Med (2004) 1.18
Post-transcriptional regulation of tumour necrosis factor alpha production. Ann Rheum Dis (2000) 0.98
Cryopyrin activates the inflammasome in response to toxins and ATP. Nature (2006) 18.74
Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature (2004) 14.80
De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature (2004) 12.41
Non-canonical inflammasome activation targets caspase-11. Nature (2011) 8.85
IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis. Cell (2007) 8.48
Ubiquitin chain editing revealed by polyubiquitin linkage-specific antibodies. Cell (2008) 5.37
Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7. Nature (2011) 5.32
Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science (2013) 5.06
The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature (2004) 5.05
Innate immunity against Francisella tularensis is dependent on the ASC/caspase-1 axis. J Exp Med (2005) 5.00
The Birc1e cytosolic pattern-recognition receptor contributes to the detection and control of Legionella pneumophila infection. Nat Immunol (2006) 4.70
Absent in melanoma 2 is required for innate immune recognition of Francisella tularensis. Proc Natl Acad Sci U S A (2010) 4.57
Redundant roles for inflammasome receptors NLRP3 and NLRC4 in host defense against Salmonella. J Exp Med (2010) 4.52
Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival. Nature (2009) 4.12
Kinase RIP3 is dispensable for normal NF-kappa Bs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and Toll-like receptors 2 and 4. Mol Cell Biol (2004) 4.05
Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO. Nature (2003) 3.96
DUBA: a deubiquitinase that regulates type I interferon production. Science (2007) 3.88
Glyburide inhibits the Cryopyrin/Nalp3 inflammasome. J Cell Biol (2009) 3.85
Inflammasomes: guardians of cytosolic sanctity. Immunol Rev (2009) 3.58
Caspase-11 increases susceptibility to Salmonella infection in the absence of caspase-1. Nature (2012) 3.40
Human De-etiolated-1 regulates c-Jun by assembling a CUL4A ubiquitin ligase. Science (2004) 3.28
Regulation of NF-kappaB-dependent lymphocyte activation and development by paracaspase. Science (2003) 3.28
A NOD2-NALP1 complex mediates caspase-1-dependent IL-1beta secretion in response to Bacillus anthracis infection and muramyl dipeptide. Proc Natl Acad Sci U S A (2008) 3.27
Inflammasomes and their roles in health and disease. Annu Rev Cell Dev Biol (2012) 3.18
The BH3-only protein bid is dispensable for DNA damage- and replicative stress-induced apoptosis or cell-cycle arrest. Cell (2007) 3.13
Signaling in innate immunity and inflammation. Cold Spring Harb Perspect Biol (2012) 3.11
Inflammasome-dependent release of the alarmin HMGB1 in endotoxemia. J Immunol (2010) 2.88
BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2. Immunity (2002) 2.75
Loss of the tumor suppressor BAP1 causes myeloid transformation. Science (2012) 2.69
Pannexin-1 is required for ATP release during apoptosis but not for inflammasome activation. J Immunol (2011) 2.67
K11-linked polyubiquitination in cell cycle control revealed by a K11 linkage-specific antibody. Mol Cell (2010) 2.52
USP1 deubiquitinates ID proteins to preserve a mesenchymal stem cell program in osteosarcoma. Cell (2011) 2.51
Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor. Immunity (2003) 2.51
Identification of a novel homotypic interaction motif required for the phosphorylation of receptor-interacting protein (RIP) by RIP3. J Biol Chem (2001) 2.45
Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death. Nat Rev Mol Cell Biol (2011) 2.27
Association of C-terminal ubiquitin hydrolase BRCA1-associated protein 1 with cell cycle regulator host cell factor 1. Mol Cell Biol (2009) 2.26
Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis. Science (2014) 2.23
Manipulation of host cell death pathways during microbial infections. Cell Host Microbe (2010) 2.21
Signaling to NF-kappaB: regulation by ubiquitination. Cold Spring Harb Perspect Biol (2010) 2.15
Mice lacking the CARD of CARMA1 exhibit defective B lymphocyte development and impaired proliferation of their B and T lymphocytes. Curr Biol (2003) 2.04
Deubiquitinases in the regulation of NF-κB signaling. Cell Res (2010) 2.00
Engineering and structural characterization of a linear polyubiquitin-specific antibody. J Mol Biol (2011) 1.93
Deubiquitinase USP37 is activated by CDK2 to antagonize APC(CDH1) and promote S phase entry. Mol Cell (2011) 1.92
Phosphorylation of NLRC4 is critical for inflammasome activation. Nature (2012) 1.92
Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-kappa B activation. J Exp Med (2005) 1.85
Modulation of inflammasome pathways by bacterial and viral pathogens. J Immunol (2011) 1.85
COP1 is a tumour suppressor that causes degradation of ETS transcription factors. Nature (2011) 1.83
Regulation of NF-κB by deubiquitinases. Immunol Rev (2012) 1.78
Constitutive NF-kappaB activation by the t(11;18)(q21;q21) product in MALT lymphoma is linked to deregulated ubiquitin ligase activity. Cancer Cell (2005) 1.74
Fatal hepatitis mediated by tumor necrosis factor TNFalpha requires caspase-8 and involves the BH3-only proteins Bid and Bim. Immunity (2009) 1.73
ATM engages autodegradation of the E3 ubiquitin ligase COP1 after DNA damage. Science (2006) 1.64
The inflammasomes. PLoS Pathog (2009) 1.48
Improved quantitative mass spectrometry methods for characterizing complex ubiquitin signals. Mol Cell Proteomics (2010) 1.43
Phosphorylation-dependent activity of the deubiquitinase DUBA. Nat Struct Mol Biol (2012) 1.42
Distinct regulation of Ubc13 functions by the two ubiquitin-conjugating enzyme variants Mms2 and Uev1A. J Cell Biol (2005) 1.41
Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. Nat Cell Biol (2010) 1.41
Ubiquitin binding to A20 ZnF4 is required for modulation of NF-κB signaling. Mol Cell (2010) 1.41
MALT1/paracaspase is a signaling component downstream of CARMA1 and mediates T cell receptor-induced NF-kappaB activation. J Biol Chem (2004) 1.38
COP1, the negative regulator of p53, is overexpressed in breast and ovarian adenocarcinomas. Cancer Res (2004) 1.35
The inhibitor of apoptosis protein fusion c-IAP2.MALT1 stimulates NF-kappaB activation independently of TRAF1 AND TRAF2. J Biol Chem (2006) 1.32
Ubiquitin-mediated regulation of TNFR1 signaling. Cytokine Growth Factor Rev (2008) 1.24
IL-33 raises alarm. Immunity (2009) 1.24
Targeted mass spectrometric strategy for global mapping of ubiquitination on proteins. Rapid Commun Mass Spectrom (2007) 1.21
SMAC negatively regulates the anti-apoptotic activity of melanoma inhibitor of apoptosis (ML-IAP). J Biol Chem (2002) 1.17
Identification of a novel death domain-containing adaptor molecule for ectodysplasin-A receptor that is mutated in crinkled mice. Curr Biol (2002) 1.14
The crystal structures of EDA-A1 and EDA-A2: splice variants with distinct receptor specificity. Structure (2003) 1.10
BAFF/BLyS receptor 3 comprises a minimal TNF receptor-like module that encodes a highly focused ligand-binding site. Biochemistry (2003) 1.08
Myodegeneration in EDA-A2 transgenic mice is prevented by XEDAR deficiency. Mol Cell Biol (2004) 1.03
Rip2 participates in Bcl10 signaling and T-cell receptor-mediated NF-kappaB activation. J Biol Chem (2003) 1.01
Modulation of K11-linkage formation by variable loop residues within UbcH5A. J Mol Biol (2011) 0.97
Phosphorylation of Dishevelled by protein kinase RIPK4 regulates Wnt signaling. Science (2013) 0.95
A20 edits ubiquitin and autoimmune paradigms. Nat Genet (2011) 0.93
Modulation of inflammasome activity for the treatment of auto-inflammatory disorders. J Clin Immunol (2010) 0.91
Increased targeting of donor switch region and IgE in Sgamma1-deficient B cells. J Immunol (2010) 0.86
Using linkage-specific monoclonal antibodies to analyze cellular ubiquitylation. Methods Mol Biol (2012) 0.84
Unraveling TACIt functions. Nat Genet (2005) 0.78
Immunology: In command of commensals. Nature (2011) 0.77
Masking MALT1: the paracaspase's potential for cancer therapy. J Exp Med (2009) 0.77
GPS navigation of the protein-stability landscape. Nat Biotechnol (2009) 0.76
Polyclonal hyper-IgE mouse model reveals mechanistic insights into antibody class switch recombination. Proc Natl Acad Sci U S A (2013) 0.76
Unleashing cell death: the Fas-FADD complex. Nat Struct Mol Biol (2010) 0.76
Cross talk between ubiquitination and demethylation. Mol Cell Biol (2011) 0.75
Erratum: Phosphorylation and linear ubiquitin direct A20 inhibition of inflammation. Nature (2016) 0.75
An interview with Vishva M. Dixit. Trends Pharmacol Sci (2013) 0.75
Pillars article: IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science. 1997. 278: 1612-1615. J Immunol (2013) 0.75